Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Newsletter question for the vets
View:
Post by DJDawg on Feb 20, 2022 6:14pm

Newsletter question for the vets

Quick question for the vets. Newsletters seem to be post on the last day or first day of the months. Is that correct? Have they ever dropped them randomly 2/3rds of the way through a month or someting like that?
Comment by Legit62 on Feb 20, 2022 8:11pm
A lot of big hitters posting lately, news is coming and very positive vibes, lots of knowledge amongst the chosen ones, good science will produce great results, patience, like Skys1 has said, what really has changed in the last 5 months, now we have Dr Vera coming aboard, great news IMO.
Comment by winr88 on Feb 20, 2022 9:56pm
A newby's view of the 5 last newsletters only 1 is on the first day of the month and the rest are near the end and mid month. Theralase Releases 3Q21 Financial Statements and Newsletter GlobeNewswire November 29, 2021 Theralase(R) Releases Quarterly Newsletter Accesswire April 27, 2021 Theralase(R) Releases Quarterly Newsletter ...more  
Comment by floatinketucky on Feb 21, 2022 6:01am
3 end of month  1 middle of the month 1 begining of the month.   LOL
Comment by floatinketucky on Feb 21, 2022 6:07am
One thing I have noticed is... The last release on Covid research taking the next steps after the succesfull start is something that is normally covered in the newsletter.  Last year the newsletter came out on Feb 1st.    At the time I was wondering if perhaps the Newsletters are finished. I think they were something Shawn was found of.  
Comment by 99942Apophis on Feb 21, 2022 9:41am
winr88 wrote  A newby's view of the 5 last newsletters only 1 is on the first day of the month and the rest are near the end and mid month. Theralase Releases 3Q21 Financial Statements and Newsletter GlobeNewswire November 29, 2021 Theralase(R) Releases Quarterly Newsletter Accesswire April 27, 2021 Theralase(R) Releases ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250